Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 SEP 28 ... women who initiated treatment on alendronate, risedronate, teriparatide, ibandronate or raloxifene in a large U.S. health plan. One analysis showed that patients with low adherence had a ...
2009 NOV 29 ... to cancer were also gone," says Lambert.Chung then tested a second drug, raloxifene, which is used to treat breast cancer and osteoporosis, to make sure that the first ...
2009 NOV 9 ... Osteoporosis treatment was defined as initiating anti-fracture therapy (bisphosphonate, raloxifene, nasal calcitonin and teriparatide) after fracture in those previously untreated. Of the ...
2009 SEP 28 ... widely. The comparative effectiveness review found that all three drugs -- tamoxifen, raloxifene, and tibolone -- significantly reduce invasive breast cancer in midlife and older women ...
2009 NOV 16 ... According to a study from Nara, Japan, "Raloxifene acts like estrogen in preventing bone loss in postmenopausal women, but it selectively ...
2009 OCT 12 ... "The antitumorigenic efficacy of tamoxifen, raloxifene, and their combination was evaluated on 4t1 estrogen-positive murine mammary carcinoma ...
2009 OCT 7 ... investigation was to explore the impact of incubation pH on the glucuronidation of raloxifene, mycophenolic acid (MPA) and ezetimibe, which are basic, acidic and neutral compounds, ...
2009 NOV 16 ... down-regulates reactive astrogliosis." "In this study we assessed whether raloxifene and tamoxifen, two selective estrogen receptor modulators, have effects similar to ...
2009 OCT 19 ... also has a remarkably improved oral bioavailability with respect to other SERMs such as raloxifene and tamoxifen, owing to increased resistance to intestinal wall glucuronidation. In both ...
2009 SEP 28 ... protein moesin and enhanced migration and invasion of normal and Ishikawa cells. Raloxifene (RAL) does not result in moesin activation or actin remodeling. When endometrial cells ...
2009 OCT 19 ... in 'Optimized and validated spectrophotometric methods for the determination of raloxifene in pharmaceuticals using permanganate' have been presented. "Two simple and sensitive ...
2009 NOV 16 ... to assess adding vs. switching to teriparatide 20 mu g/d in patients on alendronate or raloxifene. We conducted a randomized, open-label trial," scientists in the United States report. ...
2009 NOV 1 ... of stroke and stroke death in Japanese postmenopausal women with osteoporosis exposed to raloxifene increased in comparison with those of the general Japanese female population. Safety ...
2009 OCT 19 ... (SE) in adult female Sprague Dawley rats. The selective estrogen receptor modulator raloxifene was administered 30 min before pilocarpine. An anticonvulsant barbiturate, ...
2009 NOV 2 ... equine estrogens (CEE), CEE plus medroxyprogesterone acetate (MPA), tibolone, and raloxifene on cerebral blood flow and cognitive functions. A total of 64 healthy postmenopausal ...
2009 NOV 9 ... laboratory work that led to a better understanding of how drugs like tamoxifen and raloxifene work on a molecular level to fight and prevent certain breast cancers. ...
2009 OCT 5 ... today upheld Eli Lilly and Company's (NYSE:LLY) method-of-use patents on Evista (raloxifene HCl tablets). In the case of Eli Lilly and Company v. Teva Pharmaceuticals Industries ...
